您现在的位置: 首页> 研究主题> 穴,中脘

穴,中脘

穴,中脘的相关文献在2000年到2020年内共计86篇,主要集中在中国医学、内科学、神经病学与精神病学 等领域,其中期刊论文86篇、专利文献6411篇;相关期刊10种,包括河北中医、吉林中医药、陕西中医等; 穴,中脘的相关文献由283位作者贡献,包括韩景献、于涛、付立萍等。

穴,中脘—发文量

期刊论文>

论文:86 占比:1.32%

专利文献>

论文:6411 占比:98.68%

总计:6497篇

穴,中脘—发文趋势图

穴,中脘

-研究学者

  • 韩景献
  • 于涛
  • 付立萍
  • 任媛媛
  • 刘国强
  • 刘敏
  • 啜振华
  • 常小荣
  • 张丽华
  • 张玉芬
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 刘洋; 周鹏飞; 姜亚欣; 姜楠; 刘翔; 刘佃温
    • 摘要: 目的 观察穴位埋线治疗功能性便秘的临床疗效.方法 将60例功能性便秘患者随机分为治疗组和对照组,每组30例.治疗组采用脐三穴(天枢、关元和中脘)埋线治疗,对照组取相同穴位进行针刺治疗.观察两组治疗前后排便障碍症状积分表各项评分(排便通畅度、排便时间、腹胀症状)及总分的变化情况,并比较两组临床疗效.结果 两组治疗15 d、30 d后排便障碍症状积分表各项评分与同组治疗前比较,差异均具有统计学意义(P<0.05).治疗组治疗30 d后排便障碍症状积分表各项评分及总分与对照组比较,差异均具有统计学意义(P<0.05).治疗组总有效率为93.3%,对照组为73.3%,两组比较差异具有统计学意义(P<0.05).结论 脐三穴埋线是一种治疗功能性便秘的有效方法,较针刺治疗具有更持久的疗效.
    • 周岩; 马慧卿; 杨振杰; 邵慧婷; 岳公雷; 杜广中
    • 摘要: 目的:探究电针胃下合穴与合募配伍治疗胃轻瘫的疗效差异.方法:将63例胃轻瘫患者随机分为下合穴组(32例,脱落2例)和合募配伍组(31例,脱落1例).下合穴组仅电针足三里,合募配伍组电针足三里、中脘,两组均选用连续波,频率2 Hz,留针30 min,每日1次,每周5次,连续治疗3周.比较两组患者治疗前后胃轻瘫主要症状指数(GCSI)量表总评分、胃半排空时间(T1/2)、180 min胃残留率及临床总有效率.结果:治疗后两组GCSI量表总评分、180 min胃残留率均较治疗前降低,T1/2均较治疗前缩短(P<0.01);治疗后下合穴组180 min胃残留率低于合募配伍组,T1/2短于合募配伍组(P<0.05).下合穴组总有效率为93.3%(28/30),优于合募配伍组的70.0%(21/30,P<0.05).结论:电针胃下合穴与合募配伍均可治疗胃轻瘫,但电针足三里疗效更佳,中脘与足三里配伍可能具有相互拮抗作用.
    • 王柳; 申国明; 王浩; 胡梦洁; 姚永传; 叶树
    • 摘要: 目的:研究电针胃俞募穴调节功能性消化不良(functional dyspepsia,FD)模型大鼠胃运动的中枢分子机制.方法:选用SD大鼠30只,随机分为空白组、模型组、中脘+胃俞组、胃俞组和中脘组5组,每组6只.除空白组外,其余大鼠均采用适度夹尾激怒法与不规则喂养法两种经典方法联合应用建立FD大鼠模型.中脘+胃俞组、胃俞组、中脘组相应选取"中脘"+"胃俞""胃俞""中脘"穴进行电刺激,每次20 min,每日1次,连续干预7 d.空白组与模型组不施加干预措施,模型组抓取固定.采用胃肠压力换能器记录大鼠胃窦部胃运动幅度及频率,Western blotting法测定大鼠迷走神经背核(dorsal motor nucleus of the vagus,DMV)区N-甲基-D-天冬氨酸受体(N-methyl-D-aspartate recepter,NMDAR)亚基NR1表达,酶联免疫吸附法(ELISA)法检测各组大鼠血清一氧化氮(nitric oxide,NO)含量.结果:与空白组比较,模型组胃窦运动幅度降低,DMV区NR1表达降低,血清NO含量增高(均P0.05).结论:电针胃俞募穴能够调节FD模型大鼠胃运动,可能是通过改变中枢DMV区NMDAR活性从而调节血清NO含量发挥作用的.%Objective To research the central molecular mechanism of gastric motility in functional dyspepsia (FD) rats treated with electroacupuncture (EA) at shu and mu points of stomach. Methods A total of 30 SD rats were randomized into a blank group, a model group, a Zhongwan+Weishu group, a Weishu group and a Zhongwan group, 6 rats in each group. FD rats were established by moderate clipping tail infuriation and irregular feeding except in the blank group. EA was used at"Zhongwan"(CV 12),"Weishu"(BL 21), and"Zhongwan"(CV 12) +"Weishu"(BL 21) in the corresponding groups for 7 days, once a day, and 20 min a time. No intervention was used in the blank and model groups. Grabbing and fixation were applied in the model group. Gastric antrum motion range and frequency were recorded by gastrointestinal pressure transducer. The expression of subunit NR1 of N-methyl-D-aspartate recepter (NMDAR) in dorsal motor nucleus of the vagus (DMV) was determined by Western blotting. The content of serum nitric oxide (NO) was measured by ELISA. Results Compared with the blank group, the gastric antrum motion range and NR1 in the DMV decreased and the serum NO content increased in the model group (all P0.05). Conclusion EA at the shu and mu points can regulate the gastric motility in FD rats which may be by modulating the activity of NMDAR in the central DMV region, thus regulating the serum NO content.
    • 蔡荣林; 管媛媛; 武红利; 徐春生; 李传富; 胡玲; 申国明
    • 摘要: 目的:观察胃俞募配穴针刺与胃俞、中脘单穴针刺对胃扩张受试者静息态脑功能局部一致性(regional homogeneity,ReHo)的影响及其与胃运动变化的相关性,探讨胃俞募配穴的中枢整合机制.方法:采用交叉试验设计,将24例健康受试者分3次先后纳入胃俞组、中脘组和胃俞配伍中脘组(配穴组),每次每组纳入8例,每组共纳入24例受试者,在水负荷胃扩张状态下分别接受胃俞穴、中脘穴和胃俞配伍中脘穴针刺,每次针刺前后分别进行胃电图检测和静息态脑功能磁共振成像(functional magnetic resonance imaging,fMRI)扫描,对针刺前后胃运动变化情况进行分析,对采集的fMRI图像均进行ReHo值计算,分析比较各组针刺前后和各组间ReHo变化;对针刺前后胃运动情况和ReHo变化进行相关性分析.结果:①针刺后,各组受试者胃电图振幅均明显低于针刺前(均P0.05),胃俞组及中脘组胃电图振幅均高于配穴组(均P<0.05).②与针刺前比较,胃俞募配穴针刺及胃俞、中脘单穴针刺引起了不同的大脑ReHo变化;胃俞募配穴针刺可引起右颞下回、左侧丘脑、楔前叶、后扣带回ReHo显著增高(均P<0.05),右侧颞极颞中回、距状沟、楔前叶ReHo明显减低(均P<0.05).与单穴组比较,胃俞募配穴针刺均引起了后扣带回ReHo值增高和颞极ReHo值减低(均P<0.05).③相关性分析显示,配穴组后扣带回、丘脑、楔前叶ReHo变化与胃运动振幅变化呈正相关,颞极ReHo变化与胃运动振幅变化呈负相关.结论:胃俞募配穴针刺及胃俞、中脘单穴针刺引起了不同的脑区ReHo变化.胃俞募配穴较单穴针刺可引起某些新的脑区ReHo变化,丘脑、后扣带回、楔前叶等脑区可能是胃俞募配穴针刺调节胃运动效应的重点整合脑区.胃俞募配穴针刺对胃运动的调节作用与丘脑、边缘系统和默认网络部分脑区密切相关.
    • 李宛璎; 李柳宁
    • 摘要: 目的:观察艾炷灸5-HT受体拮抗剂与单纯5-HT受体拮抗剂治疗肺癌患者使用含顺铂化疗后所致恶心呕吐的临床疗效差异及安全性.方法:将58例接受含顺铂化疗方案的肺癌患者随机分为观察组(29例)和对照组(29例).两组均于化疗第1~3天采用5-羟色胺(5-HT)受体拮抗剂预防恶心呕吐,观察组于化疗前1~3d于百会、中脘穴行艾炷灸,每天1次,每穴5壮,3d为一疗程,治疗1个疗程.于化疗后0~24 h、24~48 h、48~72 h及72~96 h 4个时间段采用罗德恶心及呕吐指数评估量表(index of nausea and vomiting and retching,INVR)评估两组患者恶心呕吐程度,观察两组患者上述各时间段恶心呕吐发生率及乏力程度,并评估安全性.结果:化疗后0~24 h、24~48 h、48~72 h、72~96 h,观察组恶心呕吐评分均明显低于对照组(均P< 0.01).观察组上述时间段恶心发生率分别为37.9%(11/29)、62.1%(18/29)、60.7%(17/28)、17.4%(4/23),对照组发生率分别为93.1%(27/29)、89.7%(26/29)、89.3%(25/28)、52.0%(13/25),观察组均低于对照组(均P< 0.05).观察组上述时间段呕吐发生率分别为10.3%(3/29)、31.0%(9/29)、32.1%(9/28)、13.0%(3/23),对照组发生率分别为37.9%(11/29)、79.3%(23/29)、82.1%(23/28)、44.0%(11/25),观察组均低于对照组(均P< 0.05).化疗后0~24 h、24~48 h、48~72 h、72~96 h,观察组患者乏力症状评分均低于对照组(均P< 0.01).两组患者在化疗过程中均未出现皮肤不良反应、腹泻、发热、过敏等不良事件.结论:艾炷灸结合5-HT受体拮抗剂能有效减轻接受顺铂化疗的肺癌患者恶心呕吐的程度及发生率,疗效优于单用5-HT受体拮抗剂,无明显不良反应.
    • 石世华; 王超; 张芮浦; 范洋; 肖元阳; 宋启明
    • 摘要: 目的:评价针灸辅助治疗不完全性肠梗阻的临床疗效.方法:通过回顾分析,将80例不完全性肠梗阻患者分为观察组和对照组,每组40例.对照组给予禁食水、胃肠减压、肠外营养、抗生素预防抗感染、灌肠通便等常规治疗;观察组在对照组治疗基础上加用针刺双侧足三里、上巨虚、下巨虚,艾条灸左阳池、中脘、气海、关元,每日1次,每次30 min.观察两组患者平均治疗天数、手术中转率、距首次自行排气时间、排便时间及进食固体食物时间.结果:观察组平均治疗天数明显短于对照组(P<0.05);观察组手术中转率明显低于对照组(P<0.05);观察组首次自行排气时间、恢复排便时间及进食固体食物时间均明显早于对照组(均P< 0.05).结论:针灸辅助治疗不完全性肠梗阻疗效显著,可以缩短治疗时间,降低手术中转率,减轻患者经济负担.
    • 贲定严; 宁炯杰; 徐寅; 罗燕; 李木清; 王云辉; 易展; 杨燕萍
    • 摘要: 目的:观察不同灸量隔姜灸对脾虚证大鼠血清三叶因子1(TFF1)和粘蛋白5AC(MUC5AC)含量,以及胃黏膜表皮生长因子受体(EGFR)蛋白表达的影响,探讨隔姜灸治疗脾虚证的可能作用机制及量效特征.方法:将75只SPF级Sprague-Dawley(SD)大鼠按随机数字表法分为空白对照组(A组)、模型组(B组)、隔姜灸3壮组(C1组)、隔姜灸6壮组(C2组)和隔姜灸9壮组(C3组),每组15只.除A组外,其余各组大鼠采用200%的大黄浓缩液4°C灌胃制作脾虚证大鼠模型.造模成功后,B组大鼠不予治疗;C1、C2和C3组大鼠分别接受3壮、6壮和9壮隔姜灸足三里和中脘治疗,连续治疗8 d.观察大鼠一般症状评分,采用酶联免疫吸附法(ELISA)检测血清中TFF1和MUC5AC含量;免疫组化法检测胃黏膜EGFR蛋白表达.结果:干预结束后,与A组比较,B组大鼠脾虚症状积分增高,C1、C2和C3组大鼠血清TFF1、MUC5AC含量及胃组织EGFR蛋白表达明显升高(均P0.05).结论:隔姜灸能改善大鼠脾虚症状,促进脾虚证大鼠胃黏膜的增殖修复,其作用机制可能与提高血清TFF1和MUC5AC含量,激活EGFR蛋白的表达相关,且灸9壮和6壮的疗效优于灸3壮,但灸9壮和灸6壮的效果相当.%Objective: To observe the effects of different doses of ginger-partitioned moxibustion on serum trefoil factor 1 (TFF1) and mucin 5AC (MUC5AC) levels, as well as the expression of epidermal growth factor receptor (EGFR) in gastric mucosa of rats with spleen deficiency syndrome, therefore, to explore the possible mechanism and the dose-effect characteristics of ginger-partitioned moxibustion in spleen deficiency syndrome. Methods: Seventy-five SPF grade Sprague-Dawley (SD) rats were randomly divided into a blank control group (group A), a model group (group B), a 3 moxa-cone ginger-partitioned moxibustion group (group C1), a 6 moxa-cone ginger-partitioned moxibustion group (group C2) and a 9 moxa-cone ginger-partitioned moxibustion group (group C3) using random number table method, 15 rats in each group. Except group A, rats in the other groups received intragastric administration of 4 °C200% concentrated Da Huang (Radix et Rhizoma Rhei) to prepare spleen deficiency syndrome model. After successful modeling, rats in group B received no treatment; rats in group C1, C2 and C3 were treated with 3, 6 and 9 moxa-cone ginger-partitioned moxibustion at Zusanli (ST 36) and Zhongwan (CV 12) respectively for 8 continuous days. The general symptom score of rats was observed. The serum levels of TFF1 and MUC5AC were detected by enzyme-linked immunosorbent assay (ELISA). The expression of EGFR protein in gastric mucosa was detected by immunohistochemistry. Results: After the treatment, compared with group A, the spleen deficiency symptom score was increased in group B, the levels of serum TFF1 and MUC5AC, the EGFR protein expression in gastric tissues of group C1, C2 and C3 were significantly increased (all P0.05). The mechanism may be related to the increase of serum TFF1 and MUC5AC levels and activation of EGFR protein. Conclusion: Ginger-partitioned moxibustion can improve the symptoms, as well as promote the proliferation and repair of gastric mucosa in rats with spleen deficiency. The therapeutic efficacy of 6 or 9 moxa-cone ginger-partitioned moxibustion is better than that of 3 moxa-cone ginger-partitioned moxibustion, while the efficacies are equivalent between 6 and 9 moxa-cone ginger-partitioned moxibustion groups.
    • 哈丽娟; 崔建; 刘晓娜; 李铁
    • 摘要: 目的 用Alexa荧光素488和594结合霍乱毒素亚单B(Alexa Fluor 488,594 conjugated cholera toxin subunit B,AF488/594-CTB)荧光双标记示踪技术揭示大鼠中脘和胃俞穴相关神经元的特异性分布规律.方法 用微量注射器将0.1% 的AF488-CTB和AF594-CTB 2种示踪剂各4 mL分别注入5只雄性Sprague Dawley大鼠相当于人体的中脘和左侧胃俞穴的部位.灌流固定后取出颈、胸、腰部脊髓和脊神经节,并制成组织切片,然后直接用荧光显微镜系统观察和记录被标记的神经元.结果 在AF488-CTB标记的与"中脘"穴相关的神经元中,其感觉和运动神经元均以胸(T)9为中心分别呈对称性分布在T6-T13的脊神经节中和T5-T10的脊髓前角第Ⅸ层的后内侧部;同时,在AF594-CTB标记的与胃俞穴相关的神经元中,其感觉和运动神经元均以T12为中心分别分布在注入侧的T8-腰(L)2脊神经节中和在T10-L1的脊髓前角第Ⅸ层的最前部.结论 应用AF488-CTB和AF594-CTB荧光双标记示踪技术成功揭示了与中脘和胃俞穴相关的感觉和运动神经元在脊神经节和脊髓均有其各自对应的节段和区域,这一规律性分布特征,为在细胞水平上深入研究两者的关系提供了神经解剖学依据.
    • 符芳姿; 王哲; 许振胜
    • 摘要: [目的]观察中药联合艾灸治疗腹泻型肠易激综合征(IBS-D)患者的临床疗效及对患者生活质量的影响.[方法]将74例IBS-D患者随机分为治疗组和对照组,每组各37例.治疗组给予自拟中药(以四神丸合参苓白术散为基础方)联合艾灸(取穴神阙、中脘、足三里、天枢、脾俞、肾俞)治疗,对照组给予口服匹维溴铵片,疗程4周.观察2组治疗前后中医证候和生活质量(QOL)的变化情况,评价2组的临床疗效及安全性.[结果](1)2组各有2例患者无法坚持服药而退出研究,即最终2组各有35例患者完成试验.(2)治疗4周后,治疗组的总有效率为91.43%,对照组为85.71%,2组疗效比较,差异无统计学意义(P>0.05).(3)治疗后,治疗组的大便泄泻、腹痛腹胀、脘腹痞满、倦怠乏力、神疲懒言、畏寒肢冷、腰膝酸软、食欲不振8个证候评分均较治疗前明显降低(P<0.01);而对照组仅大便泄泻、腹痛腹胀、脘腹痞满、倦怠乏力4个证候评分较治疗前降低(P<0.05或P<0.01);治疗组在改善各项中医证候评分方面优于对照组(P<0.05或P<0.01).(4)治疗后,2组IBS-QOL 8个项目评分均有不同程度改善(P<0.05或P<0.01),且治疗组在改善情绪状况、精神状态、睡眠状况和饮食影响方面优于对照组(P<0.05或P<0.01).(5)治疗组和对照组的不良反应发生率分别为5.71%和11.42%.[结论]中药与艾灸联合治疗IBS-D疗效确切,能明显改善患者的临床症状,提高患者的生活质量,且无明显的不良反应.
    • 张迪; 袁星星; 王炳予; 张雅丽
    • 摘要: 目的 观察合募配穴灸法治疗脾胃虚寒型慢性萎缩性胃炎(CAG)患者的临床疗效及对血清胃蛋白酶原及胃泌素的影响.方法 将符合诊断及纳入标准的63例脾胃虚寒型萎缩性胃炎患者,按照随机数字表法分为对照组(31例)和治疗组(32例),对照组给予胃复春片治疗,治疗组给予合募配穴艾灸法治疗,两组疗程均为12星期.分别评价两组临床疗效、中医症状积分及血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)及胃泌素(G17)的变化.结果 治疗组治疗后总有效率为93.8%,明显优于对照组(P<0.05);两组治疗后及随访时中医症状积分显著降低(P<0.01),且治疗组明显优于对照组(P<0.01);治疗组治疗后PGⅠ、PGR及G-17水平显著增高(P<0.01),PGⅡ较治疗前降低(P<0.05);对照组治疗后PGⅠ、PGR及G-17水平明显增高(P<0.05),两组治疗后PGⅠ、PGR及G-17组间比较,治疗组明显优于对照组(P<0.01),两组治疗后PGⅡ组间比较差异具有统计学意义(P<0.05),治疗组随访HP阳性率为3.1%,明显低于对照组(P<0.05).结论 合募配穴灸法能显著改善CAG患者临床症状,增加HP的清除率及降低复发率,其作用机制可能是通过上调PGⅠ、PGR及G-17和下调PGⅡ水平实现的.%Objective To observe the clinical efficacy of moxibustion at He-Sea plus Front-Mu points in treating chronic atrophic gastritis (CAG) due to deficient cold in spleen-stomach, and its effect on serum pepsinogen (PG) and gastrin. Method Sixty-three eligible patients with CAG due to deficient cold in spleen-stomach were divided into a control group (31 cases) and a treatment group (32 cases) by using random number table. The control group was intervened by Wei Fu Chun tablets, while the treatment group received moxibustion at He-Sea plus Front-Mu points, 12 weeks as a treatment course. Clinical efficacy, symptoms score of traditional Chinese medicine (TCM), serum PGⅠ, PG Ⅱ and gastrin levels were evaluated. Result The total effective rate was 93.8% in the treatment group, significantly better than that in the control group (P<0.05); the TCM symptoms scores dropped significantly in both groups after the treatment and in the follow-up study (P<0.01), and the treatment group was markedly superior to the control group (P<0.01); the levels of PG Ⅰ, PG Ⅰ/Ⅱ ratio (PGR) and gastrin-17 (G-17) increased significantly in the treatment group after the intervention (P<0.01), and PG Ⅱ dropped significantly (P<0.05); after the treatment, thelevels of PG I, PGR and G-17 increased significantly in the control group (P<0.05); after the intervention, the treatment group was significantly better than the control group in comparing the levels of PG Ⅰ, PGR and G-17 (P<0.01), and there was a significant difference in comparing the level of PG Ⅱ between the two groups after the intervention (P<0.05). The follow-up showed that the HP positive rate was 3.1% in the treatment group, significantly lower than that in the control group (P<0.05). Conclusion Moxibustion at He-Sea plus Front-Mu points can significantly improve CAG symptoms, enhance HT clearance and lower the relapse; its action mechanism is possibly through up-regulating PGⅠ, PGR and G-17 and down-regulating PG Ⅱ.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号